vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and Tecnoglass Inc. (TGLS). Click either name above to swap in a different company.
Tecnoglass Inc. is the larger business by last-quarter revenue ($245.3M vs $185.2M, roughly 1.3× AMICUS THERAPEUTICS, INC.). Tecnoglass Inc. runs the higher net margin — 10.6% vs 0.9%, a 9.7% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 2.4%). AMICUS THERAPEUTICS, INC. produced more free cash flow last quarter ($16.0M vs $11.4M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 12.8%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Tecnoglass Inc. is a leading manufacturer of high-performance architectural glass, aluminum windows, doors, and associated building components. It primarily caters to residential and commercial construction sectors across North America and Latin America, offering custom, energy-efficient solutions for new construction and renovation projects.
FOLD vs TGLS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $245.3M |
| Net Profit | $1.7M | $26.1M |
| Gross Margin | 85.7% | 40.0% |
| Operating Margin | 8.6% | 18.3% |
| Net Margin | 0.9% | 10.6% |
| Revenue YoY | 23.7% | 2.4% |
| Net Profit YoY | -88.5% | -44.5% |
| EPS (diluted) | $0.00 | $0.57 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | $245.3M | ||
| Q3 25 | $169.1M | $260.5M | ||
| Q2 25 | $154.7M | $255.5M | ||
| Q1 25 | $125.2M | $222.3M | ||
| Q4 24 | $149.7M | $239.6M | ||
| Q3 24 | $141.5M | $238.3M | ||
| Q2 24 | $126.7M | $219.7M | ||
| Q1 24 | $110.4M | $192.6M |
| Q4 25 | $1.7M | $26.1M | ||
| Q3 25 | $17.3M | $47.2M | ||
| Q2 25 | $-24.4M | $44.1M | ||
| Q1 25 | $-21.7M | $42.2M | ||
| Q4 24 | $14.7M | $47.0M | ||
| Q3 24 | $-6.7M | $49.5M | ||
| Q2 24 | $-15.7M | $35.0M | ||
| Q1 24 | $-48.4M | $29.7M |
| Q4 25 | 85.7% | 40.0% | ||
| Q3 25 | 88.5% | 42.7% | ||
| Q2 25 | 90.2% | 44.7% | ||
| Q1 25 | 90.7% | 43.9% | ||
| Q4 24 | 90.1% | 44.5% | ||
| Q3 24 | 90.6% | 45.8% | ||
| Q2 24 | 91.1% | 40.8% | ||
| Q1 24 | 87.7% | 38.8% |
| Q4 25 | 8.6% | 18.3% | ||
| Q3 25 | 20.3% | 25.1% | ||
| Q2 25 | -6.1% | 24.0% | ||
| Q1 25 | -6.3% | 26.7% | ||
| Q4 24 | 10.7% | 28.0% | ||
| Q3 24 | 15.3% | 28.4% | ||
| Q2 24 | 11.8% | 23.3% | ||
| Q1 24 | -25.1% | 21.3% |
| Q4 25 | 0.9% | 10.6% | ||
| Q3 25 | 10.2% | 18.1% | ||
| Q2 25 | -15.8% | 17.3% | ||
| Q1 25 | -17.3% | 19.0% | ||
| Q4 24 | 9.8% | 19.6% | ||
| Q3 24 | -4.8% | 20.8% | ||
| Q2 24 | -12.4% | 15.9% | ||
| Q1 24 | -43.9% | 15.4% |
| Q4 25 | $0.00 | $0.57 | ||
| Q3 25 | $0.06 | $1.01 | ||
| Q2 25 | $-0.08 | $0.94 | ||
| Q1 25 | $-0.07 | $0.90 | ||
| Q4 24 | $0.05 | $1.00 | ||
| Q3 24 | $-0.02 | $1.05 | ||
| Q2 24 | $-0.05 | $0.75 | ||
| Q1 24 | $-0.16 | $0.63 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $104.1M |
| Total DebtLower is stronger | $392.7M | $174.4M |
| Stockholders' EquityBook value | $274.2M | $713.1M |
| Total Assets | $949.9M | $1.3B |
| Debt / EquityLower = less leverage | 1.43× | 0.24× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | $104.1M | ||
| Q3 25 | $263.8M | $127.1M | ||
| Q2 25 | $231.0M | $140.9M | ||
| Q1 25 | $250.6M | $160.2M | ||
| Q4 24 | $249.9M | $137.5M | ||
| Q3 24 | $249.8M | $124.8M | ||
| Q2 24 | $260.1M | $129.5M | ||
| Q1 24 | $239.6M | $138.8M |
| Q4 25 | $392.7M | $174.4M | ||
| Q3 25 | $392.0M | $114.7M | ||
| Q2 25 | $391.3M | $110.6M | ||
| Q1 25 | $390.7M | $110.6M | ||
| Q4 24 | $390.1M | $111.1M | ||
| Q3 24 | $389.5M | $126.8M | ||
| Q2 24 | $388.9M | $144.7M | ||
| Q1 24 | $388.4M | $160.9M |
| Q4 25 | $274.2M | $713.1M | ||
| Q3 25 | $230.4M | $764.0M | ||
| Q2 25 | $204.3M | $736.0M | ||
| Q1 25 | $193.6M | $685.1M | ||
| Q4 24 | $194.0M | $631.2M | ||
| Q3 24 | $178.8M | $613.3M | ||
| Q2 24 | $132.5M | $574.8M | ||
| Q1 24 | $130.7M | $573.6M |
| Q4 25 | $949.9M | $1.3B | ||
| Q3 25 | $868.8M | $1.2B | ||
| Q2 25 | $815.3M | $1.2B | ||
| Q1 25 | $789.8M | $1.1B | ||
| Q4 24 | $785.0M | $1.0B | ||
| Q3 24 | $786.6M | $996.3M | ||
| Q2 24 | $749.5M | $942.5M | ||
| Q1 24 | $721.8M | $981.6M |
| Q4 25 | 1.43× | 0.24× | ||
| Q3 25 | 1.70× | 0.15× | ||
| Q2 25 | 1.92× | 0.15× | ||
| Q1 25 | 2.02× | 0.16× | ||
| Q4 24 | 2.01× | 0.18× | ||
| Q3 24 | 2.18× | 0.21× | ||
| Q2 24 | 2.93× | 0.25× | ||
| Q1 24 | 2.97× | 0.28× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $31.0M |
| Free Cash FlowOCF − Capex | $16.0M | $11.4M |
| FCF MarginFCF / Revenue | 8.6% | 4.7% |
| Capex IntensityCapex / Revenue | 0.2% | 8.0% |
| Cash ConversionOCF / Net Profit | 9.62× | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $34.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $31.0M | ||
| Q3 25 | $35.7M | $40.0M | ||
| Q2 25 | $-26.5M | $17.9M | ||
| Q1 25 | $7.8M | $46.9M | ||
| Q4 24 | $-3.9M | $61.1M | ||
| Q3 24 | $-23.0M | $41.5M | ||
| Q2 24 | $22.7M | $34.5M | ||
| Q1 24 | $-29.7M | $33.4M |
| Q4 25 | $16.0M | $11.4M | ||
| Q3 25 | $35.3M | $21.2M | ||
| Q2 25 | $-28.9M | $-14.7M | ||
| Q1 25 | $7.5M | $16.5M | ||
| Q4 24 | $-4.2M | $35.4M | ||
| Q3 24 | $-23.3M | $17.8M | ||
| Q2 24 | $21.6M | $14.2M | ||
| Q1 24 | $-31.5M | $23.6M |
| Q4 25 | 8.6% | 4.7% | ||
| Q3 25 | 20.9% | 8.2% | ||
| Q2 25 | -18.7% | -5.7% | ||
| Q1 25 | 6.0% | 7.4% | ||
| Q4 24 | -2.8% | 14.8% | ||
| Q3 24 | -16.5% | 7.5% | ||
| Q2 24 | 17.0% | 6.5% | ||
| Q1 24 | -28.5% | 12.2% |
| Q4 25 | 0.2% | 8.0% | ||
| Q3 25 | 0.2% | 7.2% | ||
| Q2 25 | 1.6% | 12.7% | ||
| Q1 25 | 0.2% | 13.7% | ||
| Q4 24 | 0.2% | 10.7% | ||
| Q3 24 | 0.3% | 9.9% | ||
| Q2 24 | 0.9% | 9.2% | ||
| Q1 24 | 1.6% | 5.1% |
| Q4 25 | 9.62× | 1.19× | ||
| Q3 25 | 2.06× | 0.85× | ||
| Q2 25 | — | 0.41× | ||
| Q1 25 | — | 1.11× | ||
| Q4 24 | -0.27× | 1.30× | ||
| Q3 24 | — | 0.84× | ||
| Q2 24 | — | 0.98× | ||
| Q1 24 | — | 1.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
TGLS
| Product Sales | $164.2M | 67% |
| Fixed Price Contracts | $81.1M | 33% |
| Related Party | $692.0K | 0% |
